Kiromic BioPharma Inc. (KRBP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kiromic BioPharma Inc.

    OTC: KRBP · Real-Time Price · USD
    0.20
    0.00 (0.05%)
    At close: Mar 24, 2025, 3:59 PM

    Kiromic BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.14M 3.2M 645.2K 25.35M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 21K 21.4K 24.4K 31.1K
    Receivables
    		 n/a n/a n/a 16.2K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.16M 1.23M 1.04M 1.7M
    Total Current Assets
    		 3.3M 4.43M 1.69M 27.07M
    Property-Plant & Equipment
    		 5.22M 7.72M 10.25M 3.63M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 5.24M 7.74M 10.28M 3.66M
    Total Assets
    		 8.54M 12.17M 11.97M 30.73M
    Account Payables
    		 2.68M 2.14M 7.31M 2.21M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 685K 14M 4.37M 454.5K
    Other Current Liabilities
    		 16.86M 2.75M 355K 467.1K
    Total Current Liabilities
    		 20.9M 20.38M 13.28M 3.41M
    Long-Term Debt
    		 13.47M n/a 2.91M n/a
    Other Long-Term Liabilities
    		 -228K n/a n/a n/a
    Total Long-Term Liabilities
    		 13.47M 911.5K 4.46M n/a
    Total Liabilities
    		 21.13M 21.29M 17.74M 3.41M
    Total Debt
    		 14.57M 15.54M 9.41M 454.5K
    Common Stock
    		 2K 1.26K 648.00 9.3K
    Retained Earnings
    		 -149.79M -122.9M -101.95M -67.22M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 -12.59M -9.12M -5.77M 27.32M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist